ClinicalTrials.gg
Not yet recruitingNCT07425964Updated Feb 23, 2026

Sleep Hygiene Education to Improve Sleep in Chronic Migraine and Back Pain

An interventional study of Sleep Hygiene Education in Migraine Disorder, Low Back Pain and Chronic Pain, sponsored by Aalborg University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-23.

Sponsored by Aalborg University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether sleep hygiene education can improve sleep quality and reduce pain in adults with migraine and/or chronic lower back pain. Poor sleep is common in people with chronic pain and may worsen symptoms. Improving sleep may help break this cycle.

The main questions this study aims to answer are:

  1. Does a four-week sleep hygiene education program improve sleep quality?
  2. Does improved sleep lead to reduced pain intensity and changes in pain sensitivity?

This study does not include a comparison group. Each participant serves as their own comparison by completing the same tests before and after the sleep hygiene program.

Participants will:

  • Attend two study visits lasting 30-60 minutes, one at the beginning and one after four weeks
  • Complete questionnaires about sleep, pain, mood, and quality of life at both visits
  • Undergo pain sensitivity testing using light pinprick stimulations on the forearm
  • Receive individual sleep hygiene education and written materials to use at home for four weeks
  • Complete a short weekly online check-in about sleep habits and pain
  • Complete a three-month follow-up questionnaire about sleep habits, sleep quality, and pain
02

Conditions studied

  • Migraine Disorder
  • Low Back Pain
  • Chronic Pain
  • Sleep Disorder (Disorder)

Keywords

  • Sleep Quality
  • Sleep Hygiene
  • Pain Sensitivity
03

In context

Migraine Disorders

1,657 studies on the registry are indexed under Migraine Disorders; 339 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 1,269 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

Aalborg University is the lead sponsor of 182 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic back pain (average pain VAS ≥ 3) AND/OR Migraine (migraine or tension headaches ≥15 days per month with ≥8 days being migraine)
  • Lasting ≥3 months
  • Adults ≥18 years old
  • Read, speak, and understand Danish
  • Willing to implement sleep hygiene for four weeks
  • Digital competencies (sufficient to answer questionnaires online)

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Drug addiction, defined as the use of cannabis, opioids, or other drugs
  • Malignant comorbidity (e.g., cancer)
  • Neurological conditions affecting cognition (e.g., multiple sclerosis, epilepsy, dementia, previous stroke/transient cerebral ischemia)
  • Intake of acute headache medication on ≥15 days/month for simple analgesics/NSAIDs or ≥10 days/month for triptans, ergotamine, opioids, or combinations thereof over 3 months.
  • Use of unstable sleep-modulating pharmacological treatment (e.g., melatonin, tricyclic antidepressants)
  • Diagnosed sleep disorder (e.g., insomnia, narcolepsy, sleep apnoea)
  • Night-shift work
  • Initiation of any new therapy during the study period
  • The subject is assessed as unable to engage in the necessary cooperation required by the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Sleep Hygiene Education

    Participants receive a structured sleep hygiene education program during the first study visit, including verbal instructions and written materials covering consistent sleep routines, sleep environment optimization, evening habits, and reduction of stimulants and screen use. Participants are asked to apply the recommendations in daily life for four weeks and complete weekly online check-ins. At the second visit, they repeat questionnaires and sensory testing to evaluate changes from baseline.

    Behavioral: Sleep Hygiene Education

Interventions

  • BehavioralSleep Hygiene Education

    The intervention consists of a structured and standardized sleep hygiene education program delivered in a single in-person session. Participants receive verbal instruction and written materials outlining evidence-based recommendations for improving sleep habits. The content focuses on establishing consistent bedtimes and wake times, creating a good sleep environment, reducing evening exposure to stimulants and electronic devices, developing calming nighttime routines, and adopting healthy daytime behaviors. Participants implement these strategies independently for four weeks.

06

What researchers measure

Primary outcomes

  1. Change in Sleep Quality (PSQI Global Score)

    Sleep quality is measured using the Pittsburgh Sleep Quality Index (PSQI), a validated questionnaire summarized into a global sleep quality score (0-21). Higher scores indicate poorer sleep quality. The primary outcome is the change in PSQI global score after four weeks of sleep hygiene education.

    Time frame: Baseline (Visit 1) to 4 weeks (Visit 2)

Secondary outcomes

  1. Change in Sleep Hygiene Behaviors (Sleep Hygiene Index, SHI)

    Sleep hygiene behaviors are measured using the Sleep Hygiene Index (SHI), which assesses engagement in behaviors that negatively impact sleep. Higher scores reflect poorer sleep hygiene. Changes across time points will be assessed.

    Time frame: Baseline (Visit 1) to 4 weeks (Visit 2); Week 1; Week 2; Week 3; 3-month follow-up

  2. Change in Temporal Summation of Pain (Pinprick Sensitivity Test)

    Temporal summation is assessed using a standardized pinprick protocol on the volar forearm. Participants provide pain ratings for a single stimulus and for the last of 10 consecutive stimuli. The outcome is the change in temporal summation response.

    Time frame: Baseline (Visit 1) to 4 weeks (Visit 2)

  3. Change in PainDetect

    PainDetect assesses neuropathic and centrally mediated pain components. Higher scores indicate a higher likelihood of central sensitization.

    Time frame: Baseline (Visit 1) to 4 weeks (Visit 2)

  4. Change in Headache Impact (HIT-6) - for migraine participants only

    The HIT-6 assesses the functional impact of headaches. Higher scores indicate greater impairment.

    Time frame: Baseline (Visit 1) to 4 weeks (Visit 2)

  5. Long-Term Maintenance of Sleep Hygiene Index, SHI

    Assessed via an online questionnaire evaluating whether changes in SHI scores persist three months after the intervention period. Higher scores reflect poorer sleep hygiene adherence.

    Time frame: 4 weeks (Visit 2) to 3-month post-intervention follow-up (remote)

  6. Long-Term Maintenance of PSQI

    Assessed via an online questionnaire evaluating whether changes in PSQI persist three months after the intervention period. Higher scores indicate poorer quality of sleep.

    Time frame: 4 weeks (Visit 2) to 3-month post-intervention follow-up (remote)

  7. Long-Term Pain Intensity Measure - PainDetect

    Assessed via an online questionnaire evaluating whether changes in PainDetect scores persist three months after the intervention period. Higher scores indicate a higher likelihood of central sensitization.

    Time frame: 4 weeks (Visit 2) to 3-month post-intervention follow-up (remote)

  8. Long-Term Maintenance of Headache Impact (HIT-6) - for migraine participants only

    Assessed via an online questionnaire evaluating whether changes in HIT-6 persist three months after the intervention period. Higher scores indicate greater impairment.

    Time frame: 4 weeks (Visit 2) to 3-month post-intervention follow-up (remote)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07425964
Lead sponsor
Aalborg University
Responsible party
Kristian Kjær Petersen (Associate Professor, Aalborg University) — Principal investigator
First posted
Feb 23, 2026
Start date
Feb 2026 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Feb 23, 2026

Study contacts

Kristian Kjær-Staal Petersen
Contact
kkp@hst.aau.dk
+45 31697510
Emma Hertel
Contact
eh@hst.aau.dk

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion